Modification of the Antitumor Action of Cytostatic Drugs Using a Copolymer of N-Vinylpyrrolidone and 2-Methyl-5-Vinylpyridine
- Autores: Panov A.V.1,2, Kochkina Y.V.1,2, Yartsev E.I.2, Eremin D.V.1,2, Yakovleva T.A.2, Kedik S.A.1,2
- 
							Afiliações: 
							- Moscow Technology University (MITKhT)
- Institute of Pharmaceutical Technologies
 
- Edição: Volume 51, Nº 7 (2017)
- Páginas: 523-527
- Seção: Molecular Biological Problems of Drug Design and Mechanism of Drug Action
- URL: https://ogarev-online.ru/0091-150X/article/view/244693
- DOI: https://doi.org/10.1007/s11094-017-1647-7
- ID: 244693
Citar
Resumo
Simultaneous administration of a copolymer of N-vinylpyrrolidone and 2-methyl-5-vinylpyridine and cytostatic agents to mice with a variety of implanted tumors was found to increase treatment efficacy, promoting increases in survival time. This effect is of interest for further studies of the possible use of copolymer as an immunomodulator in chemotherapy.
Palavras-chave
Sobre autores
A. Panov
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
Yu. Kochkina
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
							Autor responsável pela correspondência
							Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
E. Yartsev
Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							21/32 Skolkovskoe Chaussee, Moscow, 121353						
D. Eremin
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
T. Yakovleva
Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							21/32 Skolkovskoe Chaussee, Moscow, 121353						
S. Kedik
Moscow Technology University (MITKhT); Institute of Pharmaceutical Technologies
														Email: alpqa603@mail.ru
				                					                																			                												                	Rússia, 							86 Vernadskii Prospekt, Moscow, 119571; 21/32 Skolkovskoe Chaussee, Moscow, 121353						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					